Targeting mitochondrial DNA with a platinum-based anticancer agent

Chemistry and Biology

Volumn 20, Issue 11, 2013, Pages 1323-1328

  Wisnovsky, Simon P ^a   Wilson, Justin J ^b   Radford, Robert J ^b   Pereira, Mark P ^a   Chan, Maria R ^b   Laposa, Rebecca R ^a   Lippard, Stephen J ^b   Kelley, Shana O ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOCHONDRIAL DNA; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; CELL NUCLEUS; CELL PROLIFERATION; CHEMISTRY; CONFORMATION; DOSE RESPONSE; DRUG EFFECTS; OVARIAN NEOPLASMS; PATHOLOGY; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CISPLATIN; DNA, MITOCHONDRIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MOLECULAR CONFORMATION; OVARIAN NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84888286676     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2013.08.010     Document Type: Article

References (29)

1. P.A. Andrews, and K.D. Albright Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells Cancer Res. 52 1992 1895 1901
2. F. Barragán, V. Moreno, and V. Marchán Solid-phase synthesis and DNA binding studies of dichloroplatinum(II) conjugates of dicarba analogues of octreotide as new anticancer drugs Chem. Commun. (Camb.) 31 2009 4705 4707
3. K.J. Cullen, Z. Yang, L. Schumaker, and Z. Guo Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer J. Bioenerg. Biomembr. 39 2007 43 50
4. M.S. Damian, H.K. Hedman, S.K.C. Elmroth, and U. Diederichsen Synthesis and DNA interaction of platinum complex/peptide chimera as potential drug candidates Eur. J. Org. Chem. 32 2010 6161 6170
5. S.B. Fonseca, M.P. Pereira, R. Mourtada, M. Gronda, K.L. Horton, R. Hurren, M.D. Minden, A.D. Schimmer, and S.O. Kelley Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells Chem. Biol. 18 2011 445 453
6. A.P. French, S. Mills, R. Swarup, M.J. Bennett, and T.P. Pridmore Colocalization of fluorescent markers in confocal microscope images of plant cells Nat. Protoc. 3 2008 619 628
7. S. Fulda, L. Galluzzi, and G. Kroemer Targeting mitochondria for cancer therapy Nat. Rev. Drug Discov. 9 2010 447 464
8. M. Galanski, M.A. Jakupec, and B.K. Keppler Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches Curr. Med. Chem. 12 2005 2075 2094
9. N. Graf, T.E. Mokhtari, I.A. Papayannopoulos, and S.J. Lippard Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells J. Inorg. Biochem. 110 2012 58 63
10. M. Groessl, O. Zava, and P.J. Dyson Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin Metallomics 3 2011 591 599
11. M. Hirama, S. Isonishi, M. Yasuda, and H. Ishikawa Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells Oncol. Rep. 16 2006 997 1002
12. K.L. Horton, K.M. Stewart, S.B. Fonseca, Q. Guo, and S.O. Kelley Mitochondria-penetrating peptides Chem. Biol. 15 2008 375 382
13. K.L. Horton, M.P. Pereira, K.M. Stewart, S.B. Fonseca, and S.O. Kelley Tuning the activity of mitochondria-penetrating peptides for delivery or disruption ChemBioChem 13 2012 476 485
14. S. Isonishi, M. Saitou, M. Yasuda, and T. Tanaka Mitochondria in platinum resistant cells Hum. Cell 14 2001 203 210
15. G.C. Kujoth, A. Hiona, T.D. Pugh, S. Someya, K. Panzer, S.E. Wohlgemuth, T. Hofer, A.Y. Seo, R. Sullivan, and W.A. Jobling Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging Science 309 2005 481 484
16. Levenson, C.H. January 1994. Process for making succinyl acetone. U.S. patent 5,276,180.
17. R. Mourtada, S.B. Fonseca, S.P. Wisnovsky, M.P. Pereira, X. Wang, R. Hurren, J. Parfitt, L. Larsen, R.A. Smith, and M.P. Murphy Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism PLoS ONE 8 2013 e60253
18. S. Mukhopadhyay, C.M. Barnés, A. Haskel, S.M. Short, K.R. Barnes, and S.J. Lippard Conjugated platinum(IV)-peptide complexes for targeting angiogenic tumor vasculature Bioconjug. Chem. 19 2008 39 49
19. T. Murata, H. Hibasami, S. Maekawa, T. Tagawa, and K. Nakashima Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells Biochem. Int. 20 1990 949 955
20. M.W. Ndinguri, R. Solipuram, R.P. Gambrell, S. Aggarwal, and R.P. Hammer Peptide targeting of platinum anti-cancer drugs Bioconjug. Chem. 20 2009 1869 1878
21. O.A. Olivero, C. Semino, A. Kassim, D.M. Lopez-Larraza, and M.C. Poirier Preferential binding of cisplatin to mitochondrial DNA of Chinese hamster ovary cells Mutat. Res. Lett. 346 1995 221 230
22. R.J. Parker, A. Eastman, F. Bostick-Bruton, and E. Reed Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation J. Clin. Invest. 87 1991 772 777
23. M.S. Robillard, A.P.M. Valentijn, N.J. Meeuwenoord, G.A. van der Marel, J.H. van Boom, and J. Reedijk The first solid-phase synthesis of a peptide-tethered platinum (II) complex Angew. Chem. Int. Ed. Engl. 39 2000 3096 3099
24. J.H. Santos, L.U. Hunakova, Y. Chen, C. Bortner, and B.J. Van Houten Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death J. Biol. Chem. 278 2003 1728 1734
25. J.H. Santos, J.N. Meyer, B.S. Mandavilli, and B. Van Houten Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells Methods Mol. Biol. 314 2006 183 199
26. C.A. Schneider, W.S. Rasband, and K.W. Eliceiri NIH Image to ImageJ: 25 years of image analysis Nat. Methods 9 2012 671 675
27. R.C. Todd, and S.J. Lippard Inhibition of transcription by platinum antitumor compounds Metallomics 1 2009 280 291
28. J.J. Wilson, and S.J. Lippard In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands J. Med. Chem. 55 2012 5326 5336
29. L.F. Yousif, K.M. Stewart, K.L. Horton, and S.O. Kelley Mitochondria-penetrating peptides: Sequence effects and model cargo transport ChemBioChem 10 2009 2081 2088